{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:26:23Z","timestamp":1792801583170,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007579","name":"Auburn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neuint.2021.105066","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T11:03:30Z","timestamp":1621076610000},"page":"105066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection"],"prefix":"10.1016","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3281-9913","authenticated-orcid":false,"given":"Senthilkumar S.","family":"Karuppagounder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Uthaythas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Govindarajulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7528-455X","authenticated-orcid":false,"given":"Sindhu","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koodeswaran","family":"Parameshwaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muralikrishnan","family":"Dhanasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2021.105066_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuint.2021.105066_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbrc.2016.07.103","article-title":"Alpha-synuclein and beta-amyloid - different targets, same players: calcium, free radicals and mitochondria in the mechanism of neurodegeneration","volume":"483","author":"Angelova","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2021.105066_bib3","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1873-3468.12964","article-title":"Role of mitochondrial ROS in the brain: from physiology to neurodegeneration","volume":"592","author":"Angelova","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuint.2021.105066_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuint.2021.105066_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2021.105066_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuint.2015.11.006","article-title":"Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: a (13)C NMR study","volume":"92","author":"Bagga","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2021.105066_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.jrn.2007.02.006","article-title":"Caffeine and the kidney: what evidence right now?","volume":"17","author":"Bolignano","year":"2007","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.neuint.2021.105066_bib8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nbt0898-728","article-title":"Nutraceuticals: poised for a healthy slice of the healthcare market?","volume":"16","author":"Brower","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuint.2021.105066_bib9","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1471-4159.2009.06425.x","article-title":"Inactivation of neuronal forebrain A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"111","author":"Carta","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2021.105066_bib10","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/jnr.23618","article-title":"Quercetin improves the activity of the ubiquitin-proteasomal system in 150Q mutated huntingtin-expressing cells but exerts detrimental effects on neuronal survivability","volume":"93","author":"Chakraborty","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2021.105066_bib11","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2021.105066_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","article-title":"Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum","volume":"107","author":"Chen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2021.105066_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0003-2697(66)90286-7","article-title":"A fluorometric assay for glutathione","volume":"14","author":"Cohn","year":"1966","journal-title":"Anal. Biochem."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2021.105066_bib14","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","article-title":"Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies","volume":"20","author":"Costa","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuint.2021.105066_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuint.2021.105066_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba1659","article-title":"Promising disease-modifying therapies for Parkinson's disease","volume":"11","author":"Dawson","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuint.2021.105066_bib17","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1021\/jf011702q","article-title":"Effect of roasting on the antioxidant activity of coffee brews","volume":"50","author":"del Castillo","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuint.2021.105066_bib18","first-page":"291","article-title":"Radioprotective and antioxidant action of caffeine: mechanistic considerations","volume":"34","author":"Devasagayam","year":"1996","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.neuint.2021.105066_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0005-2736(96)00040-5","article-title":"Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species","volume":"1282","author":"Devasagayam","year":"1996","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.neuint.2021.105066_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","article-title":"The role and regulation of adenosine in the central nervous system","volume":"24","author":"Dunwiddie","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2021.105066_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuint.2015.08.005","article-title":"Tea and Parkinson's disease: constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits","volume":"89","author":"Dutta","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2021.105066_bib22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5114\/aoms.2017.67284","article-title":"Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson's disease: mitochondrial DNA integrity","volume":"13","author":"Essawy","year":"2017","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.neuint.2021.105066_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0270(01)00485-X","article-title":"A simple method to measure stride length as an index of nigrostriatal dysfunction in mice","volume":"113","author":"Fernagut","year":"2002","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuint.2021.105066_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00001756-199412300-00020","article-title":"Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors","volume":"6","author":"Ferre","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuint.2021.105066_bib25","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4103\/1673-5374.194706","article-title":"The status of Nrf2-based therapeutics: current perspectives and future prospects","volume":"11","author":"Gazaryan","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuint.2021.105066_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1088\/0952-4746\/19\/2\/306","article-title":"Caffeine protects mice against whole-body lethal dose of gamma-irradiation","volume":"19","author":"George","year":"1999","journal-title":"J. Radiol. Prot."},{"key":"10.1016\/j.neuint.2021.105066_bib27","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1021\/jf0710985","article-title":"In vitro antioxidant activity of coffee compounds and their metabolites","volume":"55","author":"Gomez-Ruiz","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuint.2021.105066_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.23866","article-title":"Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease","volume":"73","author":"Goncalves","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2021.105066_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0161-813X(02)00164-X","article-title":"MPP(+) causes inhibition of cellular energy supply in cerebellar granule cells","volume":"24","author":"Gonzalez-Polo","year":"2003","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2021.105066_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/sj.bjp.0705776","article-title":"Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?","volume":"142","author":"Halliwell","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2021.105066_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","article-title":"The incidence of Parkinson's disease: a systematic review and meta-analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.neuint.2021.105066_bib32","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2006-9303","article-title":"Bacopa monniera extract reduces amyloid levels in PSAPP mice","volume":"9","author":"Holcomb","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuint.2021.105066_bib33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1534\/genetics.105.044487","article-title":"Carbonic anhydrase-related protein VIII deficiency is associated with a distinctive lifelong gait disorder in waddles mice","volume":"171","author":"Jiao","year":"2005","journal-title":"Genetics"},{"key":"10.1016\/j.neuint.2021.105066_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.expneurol.2010.02.007","article-title":"Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration","volume":"223","author":"Kachroo","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2021.105066_bib35","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.neuint.2021.105066_bib36","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1208\/ps050325","article-title":"Nutraceutical--definition and introduction","volume":"5","author":"Kalra","year":"2003","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.neuint.2021.105066_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease","volume":"54","author":"Karuppagounder","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2021.105066_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jchemneu.2016.01.007","article-title":"LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity","volume":"76","author":"Karuppagounder","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.neuint.2021.105066_bib39","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1073\/pnas.1423088112","article-title":"Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress","volume":"112","author":"Kaster","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2021.105066_bib40","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.nbd.2005.11.011","article-title":"The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat","volume":"22","author":"Lane","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2021.105066_bib41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0076-6879(90)86139-M","article-title":"Phospholipid hydroperoxide glutathione peroxidase","volume":"186","author":"Maiorino","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuint.2021.105066_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.freeradbiomed.2004.04.012","article-title":"Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases","volume":"37","author":"Mandel","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuint.2021.105066_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ptr.1514","article-title":"Neuroprotective effects of the antiparkinson drug Mucuna pruriens","volume":"18","author":"Manyam","year":"2004","journal-title":"Phytother Res."},{"key":"10.1016\/j.neuint.2021.105066_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.neuint.2021.105066_bib45","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3143\/geriatrics.38.494","article-title":"[Pathogenesis of idiopathic Parkinson's disease]","volume":"38","author":"Maruyama","year":"2001","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.neuint.2021.105066_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0972-2327.40220","article-title":"The effect of curcumin (turmeric) on Alzheimer's disease: an overview","volume":"11","author":"Mishra","year":"2008","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.neuint.2021.105066_bib47","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1046\/j.1471-4159.1994.62051906.x","article-title":"Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase B","volume":"62","author":"Mitra","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2021.105066_bib48","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.23107","article-title":"Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study","volume":"25","author":"Mizuno","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2021.105066_bib49","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0160-5402(85)90021-X","article-title":"An improved fluorimetric assay for brain monoamine oxidase","volume":"13","author":"Morinan","year":"1985","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.neuint.2021.105066_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-8993(00)02994-2","article-title":"SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"892","author":"Muralikrishnan","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2021.105066_bib51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"12","author":"Muralikrishnan","year":"1998","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2021.105066_bib52","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/aje\/kwp068","article-title":"Coffee intake, smoking, and pulmonary function in the atherosclerosis risk in communities study","volume":"169","author":"Nettleton","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.neuint.2021.105066_bib53","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2021.105066_bib54","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/mds.25076","article-title":"Caffeine and risk of Parkinson's disease in a large cohort of men and women","volume":"27","author":"Palacios","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2021.105066_bib55","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neuint.2021.105066_bib56","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.0b013e318263570d","article-title":"Caffeine for treatment of Parkinson disease: a randomized controlled trial","volume":"79","author":"Postuma","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2021.105066_bib57","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ars.2005.7.685","article-title":"Reactive oxygen and nitrogen species: weapons of neuronal destruction in models of Parkinson's disease","volume":"7","author":"Przedborski","year":"2005","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuint.2021.105066_bib58","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/B:JOBB.0000041771.66775.d5","article-title":"MPTP as a mitochondrial neurotoxic model of Parkinson's disease","volume":"36","author":"Przedborski","year":"2004","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.neuint.2021.105066_bib59","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/ggi.12123","article-title":"Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease","volume":"14","author":"Qi","year":"2014","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.neuint.2021.105066_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-291X(86)90972-1","article-title":"Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism","volume":"135","author":"Ramsay","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2021.105066_bib61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuint.2021.105066_bib62","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2021.105066_bib63","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuint.2021.105066_bib64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0076-6879(94)33023-9","article-title":"Enzymatic and immunological measurements of soluble and membrane-bound phospholipid-hydroperoxide glutathione peroxidase","volume":"233","author":"Roveri","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuint.2021.105066_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuint.2005.12.016","article-title":"L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats","volume":"49","author":"Saravanan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2021.105066_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuint.2021.105066_bib67","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2021.105066_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0278-6915(91)90056-D","article-title":"Antioxidant behaviour of caffeine: efficient scavenging of hydroxyl radicals","volume":"29","author":"Shi","year":"1991","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuint.2021.105066_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s002130051146","article-title":"Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP","volume":"147","author":"Shiozaki","year":"1999","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuint.2021.105066_bib70","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tins.2007.03.009","article-title":"Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease","volume":"30","author":"Sulzer","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2021.105066_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","article-title":"Cellular and molecular mechanisms of antioxidants in Parkinson's disease","volume":"15","author":"Sutachan","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.neuint.2021.105066_bib72","first-page":"147238","article-title":"Pharmacokinetics of caffeine following a single administration of coffee enema versus oral coffee consumption in healthy male subjects","author":"Teekachunhatean","year":"2013","journal-title":"ISRN Pharmacol."},{"key":"10.1016\/j.neuint.2021.105066_bib73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.expneurol.2003.08.002","article-title":"Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease","volume":"184","author":"Van Kampen","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2021.105066_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2015.08.012","article-title":"Neuro-nutraceuticals: the path to brain health via nourishment is not so distant","volume":"89","author":"Williams","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2021.105066_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2016.03.016","article-title":"Neuro-nutraceuticals: further insights into their promise for brain health","volume":"95","author":"Williams","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2021.105066_bib76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuroscience.2016.02.035","article-title":"Neuroprotection by caffeine in the MPTP model of Parkinson's disease and its dependence on adenosine A2A receptors","volume":"322","author":"Xu","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2021.105066_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(02)00069-1","article-title":"Caffeine's neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice","volume":"322","author":"Xu","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2021.105066_bib78","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00702-008-0019-6","article-title":"Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice","volume":"115","author":"Yokoyama","year":"2008","journal-title":"J. Neural. Transm."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018621001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018621001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:53:15Z","timestamp":1759312395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018621001121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":78,"alternative-id":["S0197018621001121"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2021.105066","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caffeine, a natural methylxanthine nutraceutical, exerts dopaminergic neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2021.105066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105066"}}